Click for best price
Targeted Therapy for Breast Cancer Market Size, Share 2023
Breast cancer?is a disease in which cells in the breast grow out of control. There are different kinds of?breast cancer.?
This report aims to provide a comprehensive presentation of the global market for Targeted Therapy for Breast Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Therapy for Breast Cancer. This report contains market size and forecasts of Targeted Therapy for Breast Cancer in global, including the following market information:
Global Targeted Therapy for Breast Cancer Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Targeted Therapy for Breast Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Brand Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Targeted Therapy for Breast Cancer include Eli Lilly and Company, Roche, Merck & Co., Novartis, Pfizer, Merck KGaA, Astellas, Janssen Biotech and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Targeted Therapy for Breast Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Therapy for Breast Cancer Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Targeted Therapy for Breast Cancer Market Segment Percentages, by Type, 2022 (%)
Brand Drugs
Generic Drug
Global Targeted Therapy for Breast Cancer Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Targeted Therapy for Breast Cancer Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Targeted Therapy for Breast Cancer Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Targeted Therapy for Breast Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Therapy for Breast Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Targeted Therapy for Breast Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company
Roche
Merck & Co.
Novartis
Pfizer
Merck KGaA
Astellas
Janssen Biotech
Bristol-Myers Squibb
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeted Therapy for Breast Cancer, market overview.
Chapter 2: Global Targeted Therapy for Breast Cancer market size in revenue.
Chapter 3: Detailed analysis of Targeted Therapy for Breast Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeted Therapy for Breast Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Targeted Therapy for Breast Cancer Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Targeted Therapy for Breast Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Therapy for Breast Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Therapy for Breast Cancer Overall Market Size
2.1 Global Targeted Therapy for Breast Cancer Market Size: 2022 VS 2029
2.2 Global Targeted Therapy for Breast Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Therapy for Breast Cancer Players in Global Market
3.2 Top Global Targeted Therapy for Breast Cancer Companies Ranked by Revenue
3.3 Global Targeted Therapy for Breast Cancer Revenue by Companies
3.4 Top 3 and Top 5 Targeted Therapy for Breast Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Targeted Therapy for Breast Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Therapy for Breast Cancer Players in Global Market
3.6.1 List of Global Tier 1 Targeted Therapy for Breast Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Therapy for Breast Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Targeted Therapy for Breast Cancer Market Size Markets, 2022 & 2029
4.1.2 Brand Drugs
4.1.3 Generic Drug
4.2 By Type - Global Targeted Therapy for Breast Cancer Revenue & Forecasts
4.2.1 By Type - Global Targeted Therapy for Breast Cancer Revenue, 2018-2023
4.2.2 By Type - Global Targeted Therapy for Breast Cancer Revenue, 2024-2029
4.2.3 By Type - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeted Therapy for Breast Cancer Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Targeted Therapy for Breast Cancer Revenue & Forecasts
5.2.1 By Application - Global Targeted Therapy for Breast Cancer Revenue, 2018-2023
5.2.2 By Application - Global Targeted Therapy for Breast Cancer Revenue, 2024-2029
5.2.3 By Application - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Targeted Therapy for Breast Cancer Market Size, 2022 & 2029
6.2 By Region - Global Targeted Therapy for Breast Cancer Revenue & Forecasts
6.2.1 By Region - Global Targeted Therapy for Breast Cancer Revenue, 2018-2023
6.2.2 By Region - Global Targeted Therapy for Breast Cancer Revenue, 2024-2029
6.2.3 By Region - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Targeted Therapy for Breast Cancer Revenue, 2018-2029
6.3.2 US Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.3.3 Canada Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.3.4 Mexico Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Targeted Therapy for Breast Cancer Revenue, 2018-2029
6.4.2 Germany Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.4.3 France Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.4.4 U.K. Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.4.5 Italy Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.4.6 Russia Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.4.8 Benelux Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Targeted Therapy for Breast Cancer Revenue, 2018-2029
6.5.2 China Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.5.3 Japan Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.5.4 South Korea Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.5.6 India Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Targeted Therapy for Breast Cancer Revenue, 2018-2029
6.6.2 Brazil Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.6.3 Argentina Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Targeted Therapy for Breast Cancer Revenue, 2018-2029
6.7.2 Turkey Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.7.3 Israel Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Targeted Therapy for Breast Cancer Market Size, 2018-2029
6.7.5 UAE Targeted Therapy for Breast Cancer Market Size, 2018-2029
7 Targeted Therapy for Breast Cancer Companies Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Company Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Targeted Therapy for Breast Cancer Major Product Offerings
7.1.4 Eli Lilly and Company Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly and Company Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Targeted Therapy for Breast Cancer Major Product Offerings
7.2.4 Roche Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Merck & Co.
7.3.1 Merck & Co. Company Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Targeted Therapy for Breast Cancer Major Product Offerings
7.3.4 Merck & Co. Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.3.5 Merck & Co. Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Targeted Therapy for Breast Cancer Major Product Offerings
7.4.4 Novartis Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Targeted Therapy for Breast Cancer Major Product Offerings
7.5.4 Pfizer Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Merck KGaA
7.6.1 Merck KGaA Company Summary
7.6.2 Merck KGaA Business Overview
7.6.3 Merck KGaA Targeted Therapy for Breast Cancer Major Product Offerings
7.6.4 Merck KGaA Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.6.5 Merck KGaA Key News & Latest Developments
7.7 Astellas
7.7.1 Astellas Company Summary
7.7.2 Astellas Business Overview
7.7.3 Astellas Targeted Therapy for Breast Cancer Major Product Offerings
7.7.4 Astellas Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.7.5 Astellas Key News & Latest Developments
7.8 Janssen Biotech
7.8.1 Janssen Biotech Company Summary
7.8.2 Janssen Biotech Business Overview
7.8.3 Janssen Biotech Targeted Therapy for Breast Cancer Major Product Offerings
7.8.4 Janssen Biotech Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.8.5 Janssen Biotech Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Major Product Offerings
7.9.4 Bristol-Myers Squibb Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Gilead Sciences
7.10.1 Gilead Sciences Company Summary
7.10.2 Gilead Sciences Business Overview
7.10.3 Gilead Sciences Targeted Therapy for Breast Cancer Major Product Offerings
7.10.4 Gilead Sciences Targeted Therapy for Breast Cancer Revenue in Global Market (2018-2023)
7.10.5 Gilead Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Targeted Therapy for Breast Cancer Market Opportunities & Trends in Global Market
Table 2. Targeted Therapy for Breast Cancer Market Drivers in Global Market
Table 3. Targeted Therapy for Breast Cancer Market Restraints in Global Market
Table 4. Key Players of Targeted Therapy for Breast Cancer in Global Market
Table 5. Top Targeted Therapy for Breast Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Targeted Therapy for Breast Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Targeted Therapy for Breast Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Targeted Therapy for Breast Cancer Product Type
Table 9. List of Global Tier 1 Targeted Therapy for Breast Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeted Therapy for Breast Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Targeted Therapy for Breast Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Targeted Therapy for Breast Cancer Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Targeted Therapy for Breast Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Targeted Therapy for Breast Cancer Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Targeted Therapy for Breast Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Targeted Therapy for Breast Cancer Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2024-2029
Table 30. Eli Lilly and Company Company Summary
Table 31. Eli Lilly and Company Targeted Therapy for Breast Cancer Product Offerings
Table 32. Eli Lilly and Company Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Eli Lilly and Company Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Targeted Therapy for Breast Cancer Product Offerings
Table 36. Roche Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Merck & Co. Company Summary
Table 39. Merck & Co. Targeted Therapy for Breast Cancer Product Offerings
Table 40. Merck & Co. Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Merck & Co. Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Targeted Therapy for Breast Cancer Product Offerings
Table 44. Novartis Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Targeted Therapy for Breast Cancer Product Offerings
Table 48. Pfizer Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Merck KGaA Company Summary
Table 51. Merck KGaA Targeted Therapy for Breast Cancer Product Offerings
Table 52. Merck KGaA Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. Merck KGaA Key News & Latest Developments
Table 54. Astellas Company Summary
Table 55. Astellas Targeted Therapy for Breast Cancer Product Offerings
Table 56. Astellas Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 57. Astellas Key News & Latest Developments
Table 58. Janssen Biotech Company Summary
Table 59. Janssen Biotech Targeted Therapy for Breast Cancer Product Offerings
Table 60. Janssen Biotech Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 61. Janssen Biotech Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Targeted Therapy for Breast Cancer Product Offerings
Table 64. Bristol-Myers Squibb Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. Gilead Sciences Company Summary
Table 67. Gilead Sciences Targeted Therapy for Breast Cancer Product Offerings
Table 68. Gilead Sciences Targeted Therapy for Breast Cancer Revenue (US$, Mn) & (2018-2023)
Table 69. Gilead Sciences Key News & Latest Developments
List of Figures
Figure 1. Targeted Therapy for Breast Cancer Segment by Type in 2022
Figure 2. Targeted Therapy for Breast Cancer Segment by Application in 2022
Figure 3. Global Targeted Therapy for Breast Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Targeted Therapy for Breast Cancer Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Targeted Therapy for Breast Cancer Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Targeted Therapy for Breast Cancer Revenue in 2022
Figure 8. By Type - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 9. By Application - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 10. By Type - Global Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 12. By Application - Global Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 14. By Region - Global Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 15. By Country - North America Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 16. US Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 20. Germany Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 21. France Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 28. China Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 32. India Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 34. Brazil Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Targeted Therapy for Breast Cancer Revenue Market Share, 2018-2029
Figure 37. Turkey Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Targeted Therapy for Breast Cancer Revenue, (US$, Mn), 2018-2029
Figure 41. Eli Lilly and Company Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck & Co. Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck KGaA Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Astellas Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Janssen Biotech Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Gilead Sciences Targeted Therapy for Breast Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
